In relation to total revenue, the pharmaceutical industry is among the biggest investors in research and development (R&D). Based on data from the Pharmaceutical Research and Manufacturers of America (PhRMA), the industry in the United States spent around 21 percent of global revenues on R&D in 2022.
Analyzing the revenues and R&D expenditure
Members of the PhRMA trade group generated global revenues of approximately 529 billion U.S. dollars in 2022, with domestic revenues accounting for nearly 70 percent of that figure. With regard to R&D expenditure, PhRMA members spent over 100 billion U.S. dollars worldwide in 2022, with spending in their domestic market accounting for almost 75 percent of the global figure.
Product lifecycles in the pharmaceutical industry
Pharmaceutical manufacturers require time and money if they are to develop new innovative medicines: it can take 10 to 15 years to develop a new medicine, at an average cost of approximately 2.6 billion U.S. dollars. Due to patents and exclusivity, brand name drugs can expect to be on the market for an average of twelve years before a generic version enters. Generics contain the same active ingredients as branded drugs but can be considerably cheaper. The healthcare system in the United States generated around 373 billion U.S. dollars in savings through generic medicines in 2021.
Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2022
Characteristic
Percentage of total revenue
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PhRMA. (August 21, 2023). Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2022 [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/265100/us-pharmaceutical-industry-spending-on-research-and-development-since-1990/
PhRMA. "Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2022." Chart. August 21, 2023. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/265100/us-pharmaceutical-industry-spending-on-research-and-development-since-1990/
PhRMA. (2023). Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2022. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/265100/us-pharmaceutical-industry-spending-on-research-and-development-since-1990/
PhRMA. "Spending of U.S. Pharmaceutical Industry for Research and Development as a Percentage of Total Revenues from 1990 to 2022." Statista, Statista Inc., 21 Aug 2023, https://www.statista.com/statistics/265100/us-pharmaceutical-industry-spending-on-research-and-development-since-1990/
PhRMA, Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2022 Statista, https://www.statista.com/statistics/265100/us-pharmaceutical-industry-spending-on-research-and-development-since-1990/ (last visited July 22, 2024)
Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2022 [Graph], PhRMA, August 21, 2023. [Online]. Available: https://www.statista.com/statistics/265100/us-pharmaceutical-industry-spending-on-research-and-development-since-1990/